ICH M9 - reverse engineering? [Regulatives / Guidelines]

posted by MSimoes – Portugal, 2020-09-17 15:56 (125 d 04:38 ago) – Posting: # 21924
Views: 402

Dear dshah,

Many thanks for your feedback. I suppose that orthogonal methods are also not required as we are not referring to complex formulations (IR only).

The CC/meeting is also crucial from the practical point of view.

Thanks, once again!
Marta

Regards,
MSimoes

Complete thread:

Activity
 Admin contact
21,308 posts in 4,444 threads, 1,489 registered users;
online 7 (1 registered, 6 guests [including 4 identified bots]).
Forum time: Wednesday 19:35 CET (Europe/Vienna)

Power: That which is wielded by the priesthood of
clinical trials, the statisticians, and a stick which they use
to beta their colleagues.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5